Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001029142-25-000012
Filing Date
2025-02-05
Accepted
2025-02-05 18:28:31
Documents
3
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1738798103.html 3  
1 FORM 3 wk-form3_1738798103.xml 3 1634
2 EX-24 powerofattorneyforsect16.htm EX-24 644
3 powerofattorneyforsect16001.jpg GRAPHIC 196866
  Complete submission text file 0001029142-25-000012.txt   274962
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15279 ALTON PARKWAY SUITE #100 IRVINE CA 92618
Business Address
SILVERNAIL LAUREN P (Reporting) CIK: 0001225755 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 25594857